Controlling aggregation propensity in A53T mutant of alpha-synuclein causing Parkinson's disease

Biochemical and Biophysical Research Communications

Volumn 387, Issue 2, 2009, Pages 305-309

  Kumar, Sonu ^a   Sarkar, Anita ^a   Sundar, Durai ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY DELHI   (India)

Author keywords

Synuclein; Aggregation propensity; Amyloid; Fibrillization; Mutants; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID; WATER;

ARTICLE; BETA SHEET; CYTOTOXICITY; FAMILIAL AMYLOIDOSIS; GENE CONTROL; GENE MUTATION; HYDROPHOBICITY; NERVE DEGENERATION; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN STABILITY; PROTEIN STRUCTURE; SOLUBILITY; THERMODYNAMICS;

ALPHA-SYNUCLEIN; AMINO ACID SUBSTITUTION; HUMANS; MUTATION; PARKINSON DISEASE; PROTEIN STABILITY; PROTEIN STRUCTURE, SECONDARY; SOLUBILITY; THERMODYNAMICS; VALINE;

EID: 67949112595     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.07.008     Document Type: Article

References (26)

1. Spillantini M.G., Schmidt M.L., Lee V.M., Trojanowski J.Q., Jakes R., and Goedert M. Alpha-synuclein in Lewy bodies. Nature 388 (1997) 839-840
2. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di Iorio G., Golbe L.I., and Nussbaum R.L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276 (1997) 2045-2047
3. Kruger R., Kuhn W., Muller T., Woitalla D., Graeber M., Kosel S., Przuntek H., Epplen J.T., Schols L., and Riess O. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet. 18 (1998) 106-108
4. Zarranz J.J., Alegre J., Gomez-Esteban J.C., Lezcano E., Ros R., Ampuero I., Vidal L., Hoenicka J., Rodriguez O., Atares B., Llorens V., Gomez Tortosa E., del Ser T., Munoz D.G., and de Yebenes J.G. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol. 55 (2004) 164-173
5. Cookson M.R. The biochemistry of Parkinson's disease. Annu. Rev. Biochem. 74 (2005) 29-52
6. Cookson M.R. Alpha-synuclein and neuronal cell death. Mol. Neurodegener. 4 (2009) 9
7. Chiti F., Calamai M., Taddei N., Stefani M., Ramponi G., and Dobson C.M. Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases. Proc. Natl. Acad. Sci. USA 99 Suppl. 4 (2002) 16419-16426
8. Chiti F., Stefani M., Taddei N., Ramponi G., and Dobson C.M. Rationalization of the effects of mutations on peptide and protein aggregation rates. Nature 424 (2003) 805-808
9. Chiti F., Taddei N., Baroni F., Capanni C., Stefani M., Ramponi G., and Dobson C.M. Kinetic partitioning of protein folding and aggregation. Nat. Struct. Biol. 9 (2002) 137-143
10. Dobson C.M. The structural basis of protein folding and its links with human disease. Philos. Trans. R. Soc. Lond. B Biol. Sci. 356 (2001) 133-145
11. Dobson C.M. Getting out of shape. Nature 418 (2002) 729-730
12. Lopez de la Paz M., and Serrano L. Sequence determinants of amyloid fibril formation. Proc. Natl. Acad. Sci. USA 101 (2004) 87-92
13. Kallberg Y., Gustafsson M., Persson B., Thyberg J., and Johansson J. Prediction of amyloid fibril-forming proteins. J. Biol. Chem. 276 (2001) 12945-12950
14. Ulmer T.S., Bax A., Cole N.B., and Nussbaum R.L. Structure and dynamics of micelle-bound human alpha-synuclein. J. Biol. Chem. 280 (2005) 9595-9603
15. Vilar M., Chou H.T., Luhrs T., Maji S.K., Riek-Loher D., Verel R., Manning G., Stahlberg H., and Riek R. The fold of alpha-synuclein fibrils. Proc. Natl. Acad. Sci. USA 105 (2008) 8637-8642
16. Berman H.M., Westbrook J., Feng Z., Gilliland G., Bhat T.N., Weissig H., Shindyalov I.N., and Bourne P.E. The Protein Data Bank. Nucleic Acids Res. 28 (2000) 235-242
17. Brooks B.R., Bruccoleri R.E., Olafson B.D., States D.J., Swaminathan S., and Karplus M. Charmm - a program for macromolecular energy, minimization, and dynamics calculations. J. Comput. Chem. 4 (1983) 187-217
18. Fernandez-Escamilla A.M., Rousseau F., Schymkowitz J., and Serrano L. Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat. Biotechnol. 22 (2004) 1302-1306
19. Wilkinson D.L., and Harrison R.G. Predicting the solubility of recombinant proteins in Escherichia coli. Biotechnology (NY) 9 (1991) 443-448
20. Smialowski P., Martin-Galiano A.J., Mikolajka A., Girschick T., Holak T.A., and Frishman D. Protein solubility: sequence based prediction and experimental verification. Bioinformatics 23 (2007) 2536-2542
21. Chen L., Oughtred R., Berman H.M., and Westbrook J. TargetDB: a target registration database for structural genomics projects. Bioinformatics 20 (2004) 2860-2862
22. Greenbaum E.A., Graves C.L., Mishizen-Eberz A.J., Lupoli M.A., Lynch D.R., Englander S.W., Axelsen P.H., and Giasson B.I. The E46K mutation in alpha-synuclein increases amyloid fibril formation. J. Biol. Chem. 280 (2005) 7800-7807
23. Giasson B.I., Murray I.V., Trojanowski J.Q., and Lee V.M. A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly. J. Biol. Chem. 276 (2001) 2380-2386
24. Davidson W.S., Jonas A., Clayton D.F., and George J.M. Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J. Biol. Chem. 273 (1998) 9443-9449
25. Ramirez-Alvarado M., Merkel J.S., and Regan L. A systematic exploration of the influence of the protein stability on amyloid fibril formation in vitro. Proc. Natl. Acad. Sci. USA 97 (2000) 8979-8984
26. Ignatova Z. Monitoring protein stability in vivo. Microb. Cell Fact. 4 (2005) 23